Taurine lowers inflammaging by regulating the NLRP3 inflammasome in macrophages.

Summary

This study identifies taurine as an immunometabolic rheostat linking cellular danger sensing to NLRP3 inflammasome activation. Taurine supplementation improved health span in aged mice and reduced mortality from sepsis and inflammasome-mediated inflammation, while mechanistic experiments showed that taurine restoration suppresses trans-Golgi network disassembly and downstream pyroptosis.

Key Findings

• Aging increased circulating taurine concentrations in humans and mice, while further taurine elevation in aged mice improved health span.
• Taurine supplementation reduced mortality from sepsis and inflammasome-mediated inflammation in aged mice.
• NLRP3 danger signals induced taurine efflux from macrophages, and taurine restoration suppressed trans-Golgi network disassembly, inflammasome activation, and pyroptosis.

Clinical Implications

Taurine-related interventions could eventually be explored as adjunctive therapies for sepsis and age-associated inflammatory disorders. Translation will require pharmacokinetic studies, dose-finding, confirmation of safety, and randomized clinical trials that distinguish effects on inflammation from effects on infection control.

Limitations

• The sepsis findings were predominantly preclinical and may not predict efficacy or safety in humans.
• The abstract does not establish the optimal taurine dose, treatment window, or whether supplementation affects pathogen clearance.

Future Directions

Future work should define taurine pharmacology in acute sepsis, evaluate pathogen-specific and age-specific effects, and test safety and efficacy in carefully designed early-phase clinical trials. Biomarker-guided selection of patients with inflammasome-dominant inflammation may improve translational success.